BioSenic S.A. (BIOS.BR)

EUR 0.0

(0.0%)

Revenue Summary of BioSenic S.A.

BioSenic S.A.'s latest annual revenue in 2023 was 543 Thousand EUR , up 104.14% from previous year.
BioSenic S.A.'s latest quarterly revenue in 2024 Q2 was 1.34 Million EUR , down 0.0% from previous quarter.
BioSenic S.A. reported a annual revenue of 266 Thousand EUR in annual revenue 2022, down -73.4% from previous year.
BioSenic S.A. reported a annual revenue of 1 Million EUR in annual revenue 2021, down 0.0% from previous year.
BioSenic S.A. reported a quarterly revenue of 1.34 Million EUR for 2024 Q1, up 1413.48% from previous quarter.
BioSenic S.A. reported a quarterly revenue of 543 Thousand EUR for 2023 FY, up 104.14% from previous quarter.

Annual Revenue Chart of BioSenic S.A. (2023 - 2012)

Historical Annual Revenue of BioSenic S.A. (2023 - 2012)

Year	Revenue	Revenue Growth
2023	543 Thousand EUR	104.14%
2022	266 Thousand EUR	-73.4%
2021	1 Million EUR	0.0%
2020	1 Million EUR	0.0%
2019	- EUR	-100.0%
2018	1 Million EUR	2339.02%
2017	41 Thousand EUR	0.0%
2016	- EUR	0.0%
2015	- EUR	0.0%
2014	- EUR	0.0%
2013	- EUR	0.0%
2012	- EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q2	1.34 Million EUR	0.0%
2024 Q1	1.34 Million EUR	1413.48%
2023 FY	543 Thousand EUR	104.14%
2023 Q1	182.5 Thousand EUR	158.87%
2023 Q2	182.5 Thousand EUR	0.0%
2023 Q3	89 Thousand EUR	-51.23%
2023 Q4	89 Thousand EUR	0.0%
2022 Q4	70.5 Thousand EUR	0.0%
2022 FY	266 Thousand EUR	-73.4%
2022 Q3	70.5 Thousand EUR	0.0%
2022 Q2	- EUR	0.0%
2021 Q4	1 Million EUR	0.0%
2021 FY	1 Million EUR	0.0%
2021 Q2	- EUR	0.0%
2020 Q4	1 Million EUR	0.0%
2020 FY	1 Million EUR	0.0%
2020 Q2	- EUR	0.0%
2019 FY	- EUR	-100.0%
2019 Q2	- EUR	0.0%
2019 Q4	- EUR	0.0%
2018 Q4	1 Million EUR	0.0%
2018 FY	1 Million EUR	2339.02%
2017 FY	41 Thousand EUR	0.0%
2016 FY	- EUR	0.0%
2015 FY	- EUR	0.0%
2014 Q3	- EUR	0.0%
2014 FY	- EUR	0.0%
2014 Q4	- EUR	0.0%
2013 Q4	- EUR	0.0%
2013 FY	- EUR	0.0%
2012 FY	- EUR	0.0%

Peer Revenue Comparison of BioSenic S.A.

Name	Revenue	Revenue Difference
Nicox S.A.	257 Thousand EUR	-111.284%
European Medical Solutions	40.56 Million EUR	98.661%
FERMENTALG	4.05 Million EUR	86.616%
argenx SE	1.13 Billion EUR	99.952%
Celyad Oncology SA	102 Thousand EUR	-432.353%
Hyloris Pharmaceuticals SA	2.08 Million EUR	73.982%
Onward Medical N.V.	532 Thousand EUR	-2.068%
Oxurion NV	263 Thousand EUR	-106.464%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	59.05%
Financière de Tubize SA	- EUR	-Infinity%
UCB SA	5.25 Billion EUR	99.99%